alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[S. 3452 Introduced in Senate (IS)]

110th CONGRESS
  2d Session
                                S. 3452

To authorize the expansion of the Fort Davis National Historic Site in 
               Fort Davis, Texas, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           September 8, 2008

Mrs. Hutchison introduced the following bill; which was read twice and 
       referred to the Committee on Energy and Natural Resources

_______________________________________________________________________

                                 A BILL

 
To authorize the expansion of the Fort Davis National Historic Site in 
               Fort Davis, Texas, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. INCREASED ACREAGE OF THE FORT DAVIS NATIONAL HISTORIC SITE.

    Public Law 87-213 (16 U.S.C. 461 note) is amended as follows:
            (1) In the first section--
                    (A) by striking ``the Secretary of the Interior'' 
                and inserting ``(a) The Secretary of the Interior'';
                    (B) by striking ``476 acres'' and inserting ``646 
                acres''; and
                    (C) by adding at the end the following:
    ``(b) The Secretary may acquire from willing sellers land 
comprising approximately 55 acres, as depicted on the map titled `Fort 
Davis Proposed Boundary Expansion', numbered 418/80,045, and dated 
April 2008. The map shall be on file and available for public 
inspection in the appropriate offices of the National Park Service. 
Upon acquisition of the land, the land shall be incorporated into the 
Fort Davis National Historic Site.''.
            (2) By repealing section 3.
                                 <all>
```
# Commission Implementing Regulation (EU) No 1140/2014Show full title

Commission Implementing Regulation (EU) No 1140/2014 of 27 October 2014 establishing the standard import values for determining            the entry price of certain fruit and vegetables         

        - Previous
        - Next

U.K.

# Commission Implementing Regulation (EU) No 1140/2014                     

# of 27 October 2014

# establishing the standard import values for determining the entry price of certain fruit and vegetables

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 1308/2013 of the European Parliament and of the Council of 17 December 2013 establishing                           a common organisation of the markets in agricultural products and repealing Council Regulations (EEC) No 922/72, (EEC) No 234/79,                           (EC) No 1037/2001 and (EC) No 1234/2007(1),                        

Having regard to Commission Implementing Regulation (EU) No 543/2011 of 7 June 2011 laying down detailed rules for the application                           of Council Regulation (EC) No 1234/2007 in respect of the fruit and vegetables and processed fruit and vegetables sectors(2), and in particular Article 136(1) thereof,                        

Whereas:

(1)Implementing Regulation (EU) No 543/2011 lays down, pursuant to the outcome of the Uruguay Round multilateral trade negotiations,                              the criteria whereby the Commission fixes the standard values for imports from third countries, in respect of the products                              and periods stipulated in Annex XVI, Part A thereto.

(2)The standard import value is calculated each working day, in accordance with Article 136(1) of Implementing Regulation (EU)                              No 543/2011, taking into account variable daily data. Therefore this Regulation should enter into force on the day of its                              publication in the *Official Journal of the European Union*,

HAS ADOPTED THIS REGULATION:

# Article 1U.K.

The standard import values referred to in Article 136 of Implementing Regulation (EU) No 543/2011 are fixed in the Annex to                     this Regulation.                  

# Article 2U.K.

This Regulation shall enter into force on the day of its publication in the *Official Journal of the European Union*.                  

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 27 October 2014.

*For the Commission,*                            

*On behalf of the President,*                            

Jerzy Plewa                            

*Director-General for Agriculture and Rural Development*                            

## ANNEXU.K.Standard import values for determining the entry price of certain fruit and vegetables

1

OJ L 347, 20.12.2013, p. 671.                           

2

OJ L 157, 15.6.2011, p. 1.
Exhibit 32.2



CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report on Form 10-K for the period ended December 31, 2003 of Docent, Inc. (the Company) as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, Neil J. Laird, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that:



| | 1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------



/s/    NEIL J. LAIRDNeil J. Laird Senior Vice President and Chief
Financial Officer Date: March 16, 2004




A signed
original of this written statement required by Section 906 has been provided to Docent, Inc. and will be retained by Docent, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
[Federal Register Volume 70, Number 170 (Friday, September 2, 2005)]
[Notices]
[Page 52380]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-17501]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Southwestern Power Administration


Integrated System Power Rates: Correction

AGENCY: Southwestern Power Administration, DOE.

ACTION: Correction to notice of proposed rate increase.

-----------------------------------------------------------------------

SUMMARY: Southwestern Area Power Administration published a document in 
the Federal Register (70 FR 48121) on August 16, 2005, announcing the 
public review and comment period on proposed rates. This rate proposal 
will increase annual system revenues approximately 7.3 percent from 
$124,325,100 to $133,342,029. Inadvertently, the amount of the proposed 
increase for the purchased power adder rate component ($227,100 or 0.2 
percent) was not included in the initial notice.

FOR FURTHER INFORMATION CONTACT: Mr. Forrest E. Reeves, Assistant 
Administrator, Office of Corporate Operations, Southwestern Power 
Administration, U.S. Department of Energy, One West Third Street, 
Tulsa, Oklahoma 74103, (918) 595-6696, <a href="/cdn-cgi/l/email-protection#b8dfddd6dd96caddddceddcbf8cbcfc8d996dfd7ce"><span class="__cf_email__" data-cfemail="563133383378243333203325162521263778313920">[email protected]</span></a>.

Corrections

    In the Federal Register on August 16, 2005, in FR Doc. 05-16190:
    Page 48121, under SUMMARY, correct the last sentence to read:
    Beginning January 1, 2006, and thereafter, the proposed rates would 
increase annual system revenues approximately 7.3 percent from 
$124,325,100 to $133,342,029, which includes an increase in the 
purchased power adder.
    Page 48122, under SUPPLEMENTARY INFORMATION, correct the last 
sentence of the third paragraph to read:
    The Revised Power Repayment Study shows that additional annual 
revenues of $9,016,929, (a 7.3 percent increase), including the 
increase in the purchased power adder, beginning January 1, 2006, are 
needed to satisfy repayment criteria.
    Page 48122, under SUPPLEMENTARY INFORMATION, correct the second 
sentence of the fourth paragraph to read:
    The proposed new rates would increase estimated annual revenues 
from $124,325,100 to $133,342,029 and would satisfy the present 
financial criteria for repayment of the project and transmission * * *.

    Dated: August 29, 2005.
Jon Worthington,
Assistant Administrator.
[FR Doc. 05-17501 Filed 9-1-05; 8:45 am]
BILLING CODE 6450-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
1 Pursuant to 5 T H C IR

. R. 47.5, the Court has determined th a t

this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. UNITED STATES COURT OF APPEALS For the Fifth Circuit

No. 97-50811 Summary Calendar

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

VERSUS

ALVARO NARVIZ-GUERRA, et al.,

Defendants,

GRACIELA JIMENEZ ARAGON,

Claimant-Appellant.

Appeal from the United States District Court For the Western District of Texas

(A-95-CR-193) August 17, 1998

Before DUHÉ, DEMOSS, and DENNIS, Circuit Judges.

PER CURIAM: 1

Graciela Jimenez Aragon ( “Aragon”) appeals the dismissal of

her third-party petition opposing the preliminary forfeiture order

of Las Moras ranch. A jury entered the order after the trial and

conviction of Alvaro Narviz Guerra and Larry Austin Grant on drug,2

money laundering, and conspiracy charges. Aragon argues that the

district court erred in dismissing her petition for lack of

s tanding, or alternatively, granting summary judgment. She also

argues that the district court violated her right to due process by

failing to hold an oral hearing, by considering evidence from the

criminal trial, and by failing to stay the final order of

forfeiture pending this appeal.

We have reviewed the record and the parties’ briefs and

affirm the district court’s finding that Aragon could not survive

a motion for summary judgment. Summary judgment requires a nonmovant to support her claim with specific facts and to show a

genuine issue of material fact exists. F E D

. R. C IV

. P RO

. 56(c); see

also Lujan v. Defenders of Wildlife

, 504 U.S. 555, 561 (1992)

(recognizing that general factual allegations may suffice to defeat

a motion to dismiss for lack of standing, but specific facts must

be shown to defeat a motion for summary judgment). Here, Aragon

has offered no proof in opposition to the motion other than her own

speculation, hearsay from unknown sources, and refere nces to

e vidence not in the record. Therefore, she fails to support her

claim of ownership with specific facts and to show that a genuine

issue of m aterial fact exists as to whether she has title and

whether her parents had any interest in the p roperty. M elton v.

Teachers Ins. & A nnuity Ass’n of America , 114 F.3d 557, 559 (5th

Cir. 1997).

We do not address Aragon’s remaining claims because her lack

of standing renders them moot.3

AFFIRMED.
ims-ex103_370.htm



 

Exhibit 10.3

 

Fourth Amendment
to the
IMS HEALTH INCORPORATED RETIREMENT EXCESS PLAN

This AMENDMENT NO. 4, dated as of May 3, 2016 (this “Amendment”), to that certain IMS Health Incorporated Retirement Excess Plan, as amended and restated effective January 1, 2005, as amended on March 17, 2009, December 8, 2009 and April 5, 2011 (the “Plan”).

W I T N E S S E T H:

WHEREAS the board of directors of IMS Health Incorporated (the “Company”) desires to amend Section 3.6(a)(ii) of the Plan.

NOW THEREFORE, it is hereby acknowledged and agreed that:

1.Defined Terms.  Capitalized terms used herein, but not defined herein, have the respective meanings ascribed thereto in the Plan.

2.Amendment. 

Section 3.6(a)(ii) of the Plan is hereby amended by adding the following to the end of such section:

“Notwithstanding the foregoing, in no event shall the execution of the Agreement and Plan of Merger by and between IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. dated May 3, 2016, as may be amended, the announcement of the potential transaction contemplated by such agreement nor the consummation of the transaction contemplated by such agreement, constitute a Potential Change in Control or a Change in Control for purposes of the Plan.”

3.Reference to and Effect on the Plan.  Except as specifically amended herein, the Plan shall remain in full force and effect and is hereby ratified and confirmed.  All references in the Plan to the “Plan” shall mean the Plan as amended by this Amendment.

4.Effectiveness.  This Amendment shall become effective as of the date this Amendment is approved by the board of directors of the Company.

 

 

 

 

 

 

 

 

 

 

 

 

[Signature Page to Follow]

 

 



 

 


		
	
Very truly yours,

	
 
	
 

	
IMS HEALTH INCORPORATED

	
 
	
 

	
By:
	
/s/ Harvey A. Ashman

	
 
	
Name:    Harvey A. Ashman

	
 
	
Title:    Secretary




 

Effective Date:    May 3, 2016
Exhibit 99.9



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002



In connection with the Annual Report of Compton
Petroleum Corporation (the "Company") on the Form 40-F for the fiscal year ending December 31, 2011 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), the undersigned certifies, pursuant to 18 U.S.C.
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:



| | 1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange
Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------



DATED this 7th day of March, 2012.



|/s/ C.W. Leigh Cassidy                             | 
|-------------------------------------------------- | 
|C.W. Leigh Cassidy                                
|Vice President, Finance & Chief Financial Officer,
|Compton Petroleum Corporation
**EXHIBIT 32.1****CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. §1350,AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**The undersigned, the Chief Executive Officer and the Chief Financial Officer of Equity OfficeProperties Trust, the general partner of EOP Operating Limited Partnership (the “Company”), eachhereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002 that to his / her knowledge, on the date hereof:(a) the Form 10-K/A of the Company for the annual period ended December31, 2005, filed on the date hereof with the Securities and ExchangeCommission (the “Report”) fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934; and (b) information contained in the Report fairly presents, in all materialrespects, the financial condition and results of operations of theCompany.Date: July 24, 2006         /s/ Richard D. Kincaid   Richard D. Kincaid   *President and Chief Executive Officer*
##### 



Exhibit 32.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 906 OF SARBANES  OXLEY ACT OF 2002 In connection with the accompanying Quarterly Report on Form 10-Q of
Selkirk Cogen Partners, L.P. for the quarter ended June 30, 2004, I, J. Tracy
Mey, Controller and Chief Accounting Officer of JMC Selkirk, Inc., as Managing
General Partner of Selkirk Cogen Partners, L.P., hereby certify pursuant to 18
U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002,
to the best of my knowledge and belief, that:  (1)
    
    such Quarterly Report on Form 10-Q for the quarter ended June
30, 2004, fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and(2)
    
    the information contained in such Quarterly Report on Form 10-Q
for the quarter ended June 30, 2004, fairly presents, in all
material respects, the financial condition and results of
operations of Selkirk Cogen Partners, L.P. August 12, 2004
    
    /s/ J. TRACY MEYJ. Tracy MeyController and Chief Accounting OfficerJMC Selkirk, Inc.
 A signed original of this written statement required by Section 906 has been
provided to JMC Selkirk, Inc. and will be retained by JMC Selkirk, Inc. and
furnished to the Securities and Exchange Commission or its staff upon request.
STATE v. Mark Anthony CHAMBERLAIN.

No. 86P08.

Supreme Court of North Carolina.

February 6, 2008.

Chris Z. Sinha, Assistant Attorney General, Robert F. Johnson, District Attorney, for State of NC.

The following order has been entered on the motion filed on the 15th day of February 2008 by Defendant for "Petition for Discretionary Review":

"Motion Dismissed by order of the Court in conference this the 6th day of March 2008."
STATE of North Carolina v. Elizabeth Paige McMAHAN.

No. 657PA05.

Supreme Court of North Carolina.

December 19, 2006.

Robert C. Montgomery, Assistant Attorney General, Roxann Vaneekhoven, District Attorney, for State.

Matthew D. Wunsche, Assistant Appellate Defender, for McMahan.

Prior report: 174 N.C.App. 586, 621 S.E.2d 319.

*ORDER*

Upon consideration of the petition filed on the 29th day of November 2005 by Attorney General in this matter for discretionary review of the decision of the North Carolina Court of Appeals pursuant to G.S. 7A-31, the following order was entered and is hereby certified to the North Carolina Court of Appeals:

"Allowed by order of the Court in conference, this the 19th day of December 2006."

Upon consideration of the petition filed by Attorney General on the 29th day of November 2005 for Writ of Supersedeas of the judgment of the Court of Appeals, the following order was entered and is hereby certified to the North Carolina Court of Appeals:

"Allowed by order of the Court in conference, this the 19th day of December 2006."

Therefore the case is docketed as of the date of this order's certification. Briefs of the respective parties shall be submitted to this Court within the times allowed and in the manner provided by Appellate Rule 15(g)(2).
**Exhibit 3.2**

 

**CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION**

 

NovaDel Pharma Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify:

 

**FIRST:**  The name of the Corporation is NovaDel Pharma Inc. (the “Corporation”).

 

**SECOND:**  The date on which the Corporation’s original Certificate of Incorporation was filed with the Secretary of State of the State of Delaware is November 24, 1998.

 

**THIRD:**  The Board of Directors of the Corporation, acting in accordance with the provisions of Sections 141 and 242 of the General Corporation Law of the State of Delaware, adopted resolutions dated November 17, 2006 to amend Article IV, Section 4.1 of the Certificate of Incorporation of the Corporation to read in its entirety as follows:

 

“4.1 Authorized Stock. The total number of shares of all classes of stock which the Corporation shall have authority to issue is two hundred and one million (201,000,000) shares, which are to be divided into two classes as follows:

 

200,000,000 shares of Common Stock, par value $.001 per share; and 

 

1,000,000 shares of Preferred Stock, par value $.001 per share.”

 

**FOURTH:**  The foregoing amendment was submitted to the stockholders of the Corporation for their approval and was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

 

**IN WITNESS WHEREOF,** NovaDel Pharma Inc. has caused this Certificate of Amendment to be signed by its duly authorized officers this 16th day of January, 2007.

 

 

|   |                                            |
|--------|-------------------------------------------------|
|   | By:                                             | /s/ Michael E. Spicer |   |
|   | Michael E. Spicer                               |
|   | Chief Financial Officer and Corporate Secretary |
|        |                                                 |  |  |
# Council Decision of 17 February 2014 on the conclusion, on behalf of the European Union, of the Agreement between the European            Union and the Russian Federation on drug precursors (2014/318/EU)         

        - Previous
        - Next

U.K.

# Council Decision

# of 17 February 2014

# on the conclusion, on behalf of the European Union, of the Agreement between the European Union and the Russian Federation                        on drug precursors                     

# (2014/318/EU)

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on the Functioning of the European Union, and in particular the first subparagraph of Article                           207(4), in conjunction with Article 218(6)(a) thereof,                        

Having regard to the proposal from the European Commission,

Having regard to the consent of the European Parliament,

Whereas:

(1)The European Union and the Russian Federation should strengthen their cooperation to prevent diversion of drug precursors                              from the legal trade, in order to counter the illicit manufacture of narcotic drugs and psychotropic substances.

(2)In accordance with Council Decision 2013/263/EU(1), the Agreement between the European Union and the Russian Federation on drug precursors (‘the Agreement’) was signed on 4                              June 2013, subject to its conclusion at a later date.

(3)The Agreement should ensure full respect of fundamental rights, in particular a high level of protection for the processing                              and transfer of personal data between the Parties to the Agreement.

(4)The Agreement should be approved on behalf of the European Union,

HAS ADOPTED THIS DECISION:

# Article 1U.K.

The Agreement between the European Union and the Russian Federation on drug precursors is hereby approved on behalf of the                     Union.                  

The text of the Agreement is attached to this Decision.

# Article 2U.K.

The President of the Council shall, on behalf of the European Union, give the notification provided for in Article 11 of the                     Agreement(2).                  

# Article 3U.K.

This Decision shall enter into force on the day of its adoption.

Done at Brussels, 17 February 2014.

*For the Council*                            

*The President*                            

A. Tsaftaris                            

1

Council Decision 2013/263/EU of 13 May 2013 on the signing, on behalf of the European Union, of the Agreement between the                              European Union and the Russian Federation on drug precursors (OJ L 154, 6.6.2013, p. 5).                           

2

The date of entry into force of the Agreement will be published in the *Official Journal of the European Union* by the General Secretariat of the Council.